In conclusion, we found that PLOD1 is closely associated with the occurrence, development, and poor prognosis of GBM, especially in mesenchymal GBM, and that PLOD1 regulates GSCs proliferation, invasion, MES transition, and other malignant behaviors through the NF-κB signaling pathway. The gene discussed is NFKB1; the disease is glioblastoma.